Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.36 |
| ▸ | HSD17B14 | Q9BPX1 | 5/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MPO | P05164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18463877 | 0.87 | BACE1 (0.50) | KDM4EDYRK1AHSD17B14BACE1PDE10A | |
| SCHEMBL18463889 | 0.79 | CYP1A2 (0.53) | KDM4EHSD17B14BACE1KMT2AMAPT | |
| SCHEMBL18463776 | 0.78 | NR4A2 (0.43) | KDM4EARDYRK1APDE10AKMT2A | |
| SCHEMBL18463769 | 0.78 | BACE1 (0.48) | DYRK1ABACE1MPOCYP1A2CYP2A6 | |
| SCHEMBL18463932 | 0.77 | KDM4E (0.43) | KDM4EDYRK1ABACE1KMT2APDPK1 | |
| SCHEMBL18463860 | 0.77 | KDM4E (0.43) | KDM4EDYRK1ABACE1KMT2AMAPT | |
| SCHEMBL7170725 | 0.76 | MGAM (0.58) | KDM4EHSD17B14KMT2AMAPTPDPK1 | |
| SCHEMBL611196 | 0.75 | MGAM (0.57) | KDM4EHSD17B14KMT2AMAPTCYP1A2 | |
| SCHEMBL31080661 | 0.75 | MGAM (0.57) | KDM4EHSD17B14KMT2AMAPTCYP1A2 | |
| SCHEMBL28847805 | 0.74 | MAPT (0.49) | KDM4EKMT2AMAPTCYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3719099-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-3327100-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2018-05-30 | — | — | EP | disclosed |
| EP-2489716-B1 | Phosphorescent materials | UNIVERSAL DISPLAY CORP (US) | 2017-12-27 | — | — | EP | disclosed |
| US-20170029372-A1 | BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029372-A1 | BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE | KLK3, SHBG, ACP3 | KDM4E 3361/4885AR 29/4885DYRK1A 4851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.